De Lorgeril M, Salen P, Martin J L, Mamelle N, Monjaud I, Touboul P, Delaye J
Centre National de la Recherche Scientifique, UMR 1216, Lyon, France.
J Am Coll Cardiol. 1996 Nov 1;28(5):1103-8. doi: 10.1016/S0735-1097(96)00280-X.
We sought to describe the various cardiovascular complications that occurred in the Lyon Diet Heart Study (a secondary prevention trial testing the protective effects of a Mediterranean type of diet), to analyze their relations with the associated drug treatments and to gain insights into the possible mechanisms underlying the beneficial effects of certain nutriments.
Dietary habits are implicated in coronary heart disease, and the traditional Mediterranean diet is thought to be cardioprotective. However, the exact mechanisms of this protection are unknown.
A total of 605 patients (303 control subjects and 302 study patients) were studied over a mean period of 27 months. Major primary end points (cardiovascular death and nonfatal acute myocardial infarction), secondary end points (including unstable angina, stroke, heart failure and embolisms) and minor end points (stable angina, need for myocardial revascularization, postangioplasty restenosis and thrombophlebitis) were analyzed separately and in combination.
When major primary and secondary end points were combined, there were 59 events in control subjects and 14 events in the study patients, showing a risk reduction of 76% (p < 0.0001). When these end points were combined with the minor end points, there were 104 events in control subjects and 68 events in the study patients, giving a risk reduction of 37% (p < 0.005). By observational analysis, only aspirin among the medications appeared to be significantly protective (risk ratio after adjustment for prognosis factors 0.45; 95% confidence interval 0.25 to 0.80).
These data show a protective effect of the Mediterranean diet. However, the risk reduction varied depending on the type of end point considered. Our hypothesis is that different pathogenetic mechanisms were responsible for the development of the various complications. It is likely that certain nutriments characteristic of the Mediterranean diet (omega-3 fatty acids, oleic acid antioxidant vitamins) have specific cardioprotective effects.
我们试图描述在里昂心脏饮食研究(一项检验地中海式饮食保护作用的二级预防试验)中出现的各种心血管并发症,分析它们与相关药物治疗的关系,并深入了解某些营养素有益作用的潜在机制。
饮食习惯与冠心病有关,传统的地中海饮食被认为具有心脏保护作用。然而,这种保护的确切机制尚不清楚。
对总共605名患者(303名对照受试者和302名研究患者)进行了平均27个月的研究。分别并综合分析主要主要终点(心血管死亡和非致命性急性心肌梗死)、次要终点(包括不稳定型心绞痛、中风、心力衰竭和栓塞)和轻微终点(稳定型心绞痛、心肌血运重建需求、血管成形术后再狭窄和血栓性静脉炎)。
当主要主要终点和次要终点合并时,对照受试者中有59起事件,研究患者中有14起事件,风险降低了76%(p<0.0001)。当这些终点与轻微终点合并时,对照受试者中有104起事件,研究患者中有68起事件,风险降低了37%(p<0.005)。通过观察性分析,在这些药物中只有阿司匹林似乎具有显著的保护作用(调整预后因素后的风险比为0.45;95%置信区间为0.25至0.80)。
这些数据显示了地中海饮食的保护作用。然而,风险降低程度因所考虑的终点类型而异。我们的假设是,不同的发病机制导致了各种并发症的发生。地中海饮食特有的某些营养素(ω-3脂肪酸、油酸、抗氧化维生素)可能具有特定的心脏保护作用。